BDSX
Price
$8.02
Change
-$0.12 (-1.47%)
Updated
Dec 11 closing price
Capitalization
63.8M
Intraday BUY SELL Signals
MYO
Price
$1.05
Change
-$0.03 (-2.78%)
Updated
Dec 12, 01:05 PM (EDT)
Capitalization
41.51M
94 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDSX vs MYO

Header iconBDSX vs MYO Comparison
Open Charts BDSX vs MYOBanner chart's image
Biodesix
Price$8.02
Change-$0.12 (-1.47%)
Volume$26.94K
Capitalization63.8M
Myomo
Price$1.05
Change-$0.03 (-2.78%)
Volume$2K
Capitalization41.51M
BDSX vs MYO Comparison Chart in %
BDSX
Daily Signal:
Gain/Loss:
MYO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDSX vs. MYO commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDSX is a Buy and MYO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (BDSX: $8.02 vs. MYO: $1.08)
Brand notoriety: BDSX and MYO are both not notable
BDSX represents the Medical Specialties, while MYO is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BDSX: 16% vs. MYO: 48%
Market capitalization -- BDSX: $63.8M vs. MYO: $41.51M
BDSX [@Medical Specialties] is valued at $63.8M. MYO’s [@Medical/Nursing Services] market capitalization is $41.51M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $214.37B to $0. The average market capitalization across the [@Medical Specialties] industry is $12.5B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDSX’s FA Score shows that 0 FA rating(s) are green whileMYO’s FA Score has 1 green FA rating(s).

  • BDSX’s FA Score: 0 green, 5 red.
  • MYO’s FA Score: 1 green, 4 red.
According to our system of comparison, MYO is a better buy in the long-term than BDSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDSX’s TA Score shows that 5 TA indicator(s) are bullish while MYO’s TA Score has 5 bullish TA indicator(s).

  • BDSX’s TA Score: 5 bullish, 2 bearish.
  • MYO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BDSX is a better buy in the short-term than MYO.

Price Growth

BDSX (@Medical Specialties) experienced а -6.09% price change this week, while MYO (@Medical/Nursing Services) price change was +5.88% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.17%. For the same industry, the average monthly price growth was +0.01%, and the average quarterly price growth was +22.95%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.54%. For the same industry, the average monthly price growth was +0.19%, and the average quarterly price growth was +11.76%.

Reported Earning Dates

MYO is expected to report earnings on Mar 16, 2026.

Industries' Descriptions

@Medical Specialties (-0.17% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-0.54% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDSX($63.8M) has a higher market cap than MYO($41.5M). BDSX YTD gains are higher at: -73.791 vs. MYO (-83.230). MYO has higher annual earnings (EBITDA): -7.85M vs. BDSX (-28.07M). MYO has less debt than BDSX: MYO (12.4M) vs BDSX (72.1M). BDSX has higher revenues than MYO: BDSX (76.6M) vs MYO (40.8M).
BDSXMYOBDSX / MYO
Capitalization63.8M41.5M154%
EBITDA-28.07M-7.85M358%
Gain YTD-73.791-83.23089%
P/E RatioN/AN/A-
Revenue76.6M40.8M188%
Total CashN/A15.5M-
Total Debt72.1M12.4M581%
FUNDAMENTALS RATINGS
MYO: Fundamental Ratings
MYO
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDSXMYO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 23 days ago
90%
Bearish Trend 25 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BDSX
Daily Signal:
Gain/Loss:
MYO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LBRDK49.20-0.33
-0.67%
Liberty Broadband Corp
ZH3.35-0.04
-1.18%
Zhihu
KO69.11-1.10
-1.57%
Coca-Cola Company
JG6.72-0.11
-1.61%
Aurora Mobile Limited
ORKA30.21-1.19
-3.79%
Oruka Therapeutics Inc

BDSX and

Correlation & Price change

A.I.dvisor tells us that BDSX and ELMD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDSX and ELMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDSX
1D Price
Change %
BDSX100%
-1.47%
ELMD - BDSX
30%
Poorly correlated
+1.37%
KSRBF - BDSX
26%
Poorly correlated
N/A
RVTY - BDSX
26%
Poorly correlated
+0.40%
PLSE - BDSX
25%
Poorly correlated
-3.17%
VAPO - BDSX
24%
Poorly correlated
N/A
More

MYO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYO has been loosely correlated with NEO. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MYO jumps, then NEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYO
1D Price
Change %
MYO100%
+0.93%
NEO - MYO
33%
Loosely correlated
-1.92%
RDNT - MYO
31%
Poorly correlated
+1.98%
VMD - MYO
31%
Poorly correlated
-0.68%
NXL - MYO
31%
Poorly correlated
+1.21%
TWST - MYO
31%
Poorly correlated
-2.01%
More